Accreditation | Awards and Lectureships | How will I receive my continuing education (CE) credits? | Faculty and Moderators | Final Agenda | Final Program | Oral and Poster Abstracts | Other Information | Presentations | Virtual Take-One Table
Oral Abstracts
O01 | THE UTILITY OF SONOGRAPHIC ASSESSMENT OF INTRAUTERINE DEVICE PLACEMENT FOLLOWING IMMEDIATE VERSUS DELAYED INSERTION FOLLOWING UTERINE ASPIRATION |
O02 | TXT NOW 2 DECREASE PREGNANCIES L8R: A RANDOMIZED CONTROL TRIAL TO EVALUATE THE EFFECT OF DAILY EDUCATIONAL TEXT MESSAGES ON ORAL CONTRACEPTIVE CONTINUATION IN YOUNG URBAN WOMEN |
O03 | THE SAFETY OF DIGOXIN AS A FETICIDAL AGENT |
O04 | MUSIC AS AN AUXILIARY ANALGESIC DURING FIRST TRIMESTER SURGICAL ABORTION: A RANDOMIZED CONTROL TRIAL |
O05 | INTRODUCING MEDICAL ABORTION IN NEPAL WITH MINIMAL TECHNOLOGY |
O06 | A DOUBLE-BLINDED RANDOMIZED TRIAL OF SAME-DAY DILAPAN-S VERSUS OVERNIGHT LAMINARIA FOR CERVICAL PREPARATION BEFORE SURGICAL ABORTION BETWEEN FOURTEEN AND EIGHTEEN WEEKS’ GESTATION |
O07 | EARLY WEIGHT GAIN AND ITS RELATIONSHIP TO LATER WEIGHT GAIN IN ADOLESCENTS ON DMPA |
O08 | THE IMPACT OF PACK SUPPLY ON ORAL CONTRACEPTIVE CONTINUATION: A RANDOMIZED CONTROLLED TRIAL |
O09 | DO DEPRESSED MOOD, PSYCHOLOGICAL STRESS AND EATING DISORDERED SYMPTOMS INCREASE THE RISK FOR ORAL CONTRACEPTIVE DISCONTINUATION IN YOUNG MINORITY WOMEN? |
O10 | DOES CONVENIENCE MATTER? ORAL CONTRACEPTIVE CONTINUATION ALONG THE US-MEXICO BORDER |
O11 | COMPARISON OF THE INCIDENCE OF PELVIC INFLAMMATORY DISEASE IN INTRAUTERINE DEVICES USERS BY GONORRHEA AND CHLAMYDIA SCREENING STRATEGIES |
O12 | RATES OF CONTINUATION AND EXPULSION OF INTRAUTERINE CONTRACEPTION AT 12 MONTHS IN NULLIPAROUS AND ADOLESCENT WOMEN |
O13 | STRUCTURED CONTRACEPTIVE COUNSELING: A RANDOMIZED CONTROLLED TRIAL |
O14 | CAN PARENTS TEACH THEIR TEENS TO HAVE SAFE SEX? RESULTS OF AN EDUCATIONAL INTERVENTION FOR PARENTS IN MEXICO |
O15 | RANDOMIZED TRIAL OF HOME VERSUS CLINIC-BASED SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS IN LONG-ACTING REVERSIBLE CONTRACEPTIVE USERS |
O16 | REVITALIZING LONG ACTING REVERSIBLE CONTRACEPTIVES IN SETTINGS WITH HIGH UNMET NEED:  A MULTI-COUNTRY EXPERIENCE MATCHING DEMAND CREATION AND SERVICE DELIVERY |
O17 | PROPHYLACTIC MISOPROSTOL PRIOR TO IUD INSERTION IN NULLIPAROUS WOMEN |
O18 | RESUMPTION OF SEXUAL ACTIVITY AFTER FIRST TRIMESTER SUCTION ASPIRATION |
O19 | PREGNANCY INTENTIONS AND FAMILY PLANNING PREFERENCES AMONG HIV-INFECTED WOMEN IN NYANZA PROVINCE, KENYA |
020 | CONTRACEPTIVE AND PREGNANCY OUTCOMES: A RANDOMIZED CONTROLLED TRIAL OF IMMEDIATE VERSUS DELAYED POST-ABORTAL COPPER T 380A IUD INSERTION AFTER SECOND TRIMESTER ABORTIONS |
021 | STI/PREGNANCY PREVENTION USING TECHNOLOGY-BASED EDUCATION |
Poster Abstracts
P01 | A RANDOMIZED TRIAL OF IMMEDIATE VERSUS DELAYED INSERTION OF THE COPPER T 380Q FOLLOWING MEDICATION ABORTION |
P02 | PAIN FOLLOWING POST-ASPIRATION IUD INSERTION |
P03 | USING QUALITATIVE METHODS TO EXPLORE EC USERS WILLINGNESS TO ACCEPT THE COPPER IUD |
P04 | TRANSCESAREAN IUD INSERTION: A PROSPECTIVE COHORT STUDY |
P05 | RATES OF EXPULSION AT 6 MONTHS IN WOMEN UNDERGOING IMMEDIATE POSTABORTION INTRAUTERINE CONTRACEPTION INSERTION |
P06 | ESTIMATED COST SAVINGS WITH PROVIDING UNIVERSAL CONTRACEPTION IN THE STATE OF OREGON |
P07 | PREDICTORS OF PATIENT USE OF HIGHLY EFFECTIVE POST-PARTUM CONTRACEPTION |
P08 | EFFECTS OF ST. JOHN’S WORT ON THE PHARMACOKINETICS OF LEVONORGESTREL IN EMERGENCY CONTRACEPTIVE (EC) DOSING |
P09 | EVALUATION OF ORAL CONTRACEPTIVE EFFECTIVENESS IN A LARGE COHORT STUDY – IS ELEVATED BMI ASSOCIATED WITH REDUCED ORAL CONTRACEPTIVE EFFECTIVENESS? |
P10 | COMPARING THE CONTRACEPTIVE DECISION-MAKING OF WOMEN WHO CHOOSE AN INTRAUTERINE DEVICE VERSUS A LESS EFFECTIVE METHOD: A QUALITATIVE ANALYSIS |
P11 | COMPARING OUTCOMES FOLLOWING IMMEDIATE OR DELAYED LEVONORGESTREL-IUD INSERTION AFTER DILATION AND CURETTAGE, DILATION AND EVACUATION AND VAGINAL DELIVERY |
P12 | CONTRACEPTIVE USE AMONG WOMEN OBTAINING ABORTIONS IN 2008 |
P13 | COUPLES-BASED FAMILY PLANNING SERVICES: IS THERE A NEED? |
P14 | LEVONORGESTREL RELEASE RATES WITH LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA |
P15 | KNOWLEDGE OF CONTRACEPTIVE EFFECTIVENESS AMONG A COHORT OF ST. LOUIS WOMEN CHOOSING REVERSIBLE CONTRACEPTION |
P16 | PLASMA LEVONORGESTREL LEVELS IN WOMEN USING LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA |
P17 | CONTINUATION AND SATISFACTION OF REVERSIBLE CONTRACEPTION: A PRELIMINARY ANALYSIS FROM THE CONTRACEPTIVE CHOICE PROJECT |
P18 | UNDERSTANDING THE ATTITUDES OF BLACK, LATINO, AND WHITE COUPLES TOWARDS STERILIZATION |
P19 | CARBAMAZEPINE COADMINISTRATION WITH AN ORAL CONTRACEPTIVE: EFFECTS ON STEROID PHARMACOKINETICS, OVULATION AND BLEEDING |
P20 | WHAT DO WOMEN WANT? WOMEN’S EXPERIENCES AND PREFERENCES ABOUT CONTRACEPTIVE COUNSELING: A QUALITATIVE STUDY |
P21 | PAIN WITH IUD INSERTION FOLLOWING PROPHYLACTIC IBUPROFEN: A RANDOMIZED TRIAL |
P22 | US ADOLESCENT EXPERIENCE WITH INTRAUTERINE DEVICE INSERTION AND USE: A RETROSPECTIVE STUDY |
P23 | EMERGENCY CONTRACEPTION KNOWLEDGE AND LIKELIHOOD OF USE BY WOMEN WITH RECENT POOR PERINATAL OUTCOMES |
P24 | CONTRACEPTIVE CHOICES IN PATIENTS WITH LOW LITERACY SKILLS |
P25 | WHAT FACTORS INFLUENCE WOMEN’S CONTRACEPTIVE DECISIONS? |
P26 | FAMILY PLANNING PROVIDER ATTITUDES AND PRACTICES RELATED TO PROVISION OF CONTRACEPTIVE METHODS AMONG WOMEN WITH VARIOUS CHARACTERISTICS AND MEDICAL CONDITIONS |
P27 | MEDICAL STUDENT INTRAUTERINE CONTRACEPTION KNOWLEDGE AND ATTITUDES: EVALUATION OF OBSTETRIC AND GYNECOLOGY CLERKSHIP TRAINING |
P28 | ASSOCIATION OF AGE AND LARC METHOD CHOICE IN THE CONTRACEPTIVE CHOICE PROJECT |
P29 | UNMET NEED FOR PUBLICLY FUNDED FAMILY PLANNING IN REGION IV |
P30 | PREVALENCE OF CHLAMYDIA TRICHOMATIS AND NEISSERIA GONORRHOEA IN PATIENTS REQUESTING IUD AS POST ABORTION CONTRACEPTION IN A PUBLICLY FUNDED PREGNANCY TERMINATION CLINIC |
P31 | GIVING YOUNG WOMEN IN KENYA AN OPPORTUNITY TO USE IMPLANTS INSTEAD OF SHORT-ACTING METHODS: PROSPECTIVE STUDY TO MEASURE ACCEPTABILITY AND BENEFITS |
P32 | FACTORS ASSOCIATED WITH CHOOSING A LONG ACTING REVERSIBLE CONTRACEPTIVE METHOD AMONGST POSTPARTUM WOMEN IN AN URBAN TEACHING HOSPITAL |
P33 | EFFECT OF SUBCUTANEOUS DEPO-MEDROXYPROGESTERONE ACETATE SUBCUTANEOUS (DEPOT-MEDROXYPROGESTERONE ACETATE) ON SERUM ANDROGENIC MARKERS IN NORMAL WEIGHT, OBESE AND EXTREMELY OBESE WOMEN |
P34 | BARRIERS TO CONTRACEPTIVE USE IN TASBA-PRI, NICARAGUA |
P35 | COMMUNITY-BASED PROVISION OF DMPA IN TIGRAY, ETHIOPIA: TASK SHIFTING TO REACH WOMEN |
P36 | IUD REMOVALS IN THE EMERGENCY DEPARTMENT SETTING |
P37 | RATES OF INTRAUTERINE DEVICE DISCONTINUATION AFTER ABORTION VS. INTERVAL PLACEMENT |
P38 | METHOD SATISFACTION AMONG USERS OF POST PARTUM IUD IN EL SALVADOR |
P39 | OVARIAN SUPPRESSION IN NORMAL-WEIGHT AND OBESE WOMEN USING A CONTRACEPTIVE VAGINAL RING |
P40 | OVARIAN FOLLICULAR DEVELOPMENT DURING SIX WEEK EXTENDED USE OF A SINGLE CONTRACEPTIVE VAGINAL RING |
P41 | CONTINUATION AND ACCEPTABILITY OF THE LEVONORGESTREL INTRAUTERINE SYSTEM AND DEPO-MEDROXYPROGESTERONE ACETATE AMONG ADOLESCENTS AND YOUNG WOMEN |
P42 | THE EFFECT OF PARITY ON REASONS FOR REMOVAL OF A LEVONORGESTREL IUS |
P43 | SELF-ADMINISTRATION OF SUBCUTANEOUS DEPOT MEDROXYPROGESTERONE ACETATE BY ADOLESCENT WOMEN |
P44 | PROVISION OF POSTPARTUM CONTRACEPTION IN WOMEN WITH CHRONIC MEDICAL CONDITIONS |
P45 | USE OF A SELF-ADMINISTERED COMPUTER MODULE PROVIDING PERSONALIZED CONTRACEPTIVE RECOMMENDATIONS IN A CLINICAL SETTING |
P46 | COST ANALYSIS OF HYSTEROSCOPIC STERILIZATION VERSUS THE INTRAUTERINE DEVICE AS LONG-TERM CONTRACEPTION |
P47 | IBUPROFEN PROPHYLAXIS FOR LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM INSERTION: A RANDOMIZED CONTROLLED TRIAL |
P48 | PROVIDER OPINIONS ABOUT EXPANDING ACCESS TO HORMONAL CONTRACEPTION |
P49 | NUMBER OF ORAL CONTRACEPTIVE PILL PACKAGES DISPENSED AND SUBSEQUENT UNINTENDED PREGNANCIES |
P50 | LENGTH OF TIME AFTER INSERTION FOR THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM FOR IT TO SIGNIFICANTLY ALTER CERVICAL MUCUS QUALITY AND SPERM PENETRABILITY |
P51 | CONTRACEPTIVE CHOICES OF ADOLESCENTS IN A LARC-ORIENTED ADOLESCENT TITLE X CLINIC |
P52 | BARRIERS TO POST-PARTUM IUC USE: IMPLICATIONS FOR PATIENT CONTRACEPTIVE PREFERENCES AND SATISFACTION WITH HEALTH SERVICES |
P53 | THE IMPACT OF INSURANCE COVERAGE ON IUD UTILIZATION |
P54 | CHARACTERISTICS OF WOMEN WHO FAIL TO RETURN FOR DELAYED IUD INSERTION FOR POST-ABORTION CONTRACEPTION |
P55 | USE OF EFFECTIVE CONTRACEPTIVE METHODS AMONG WOMEN TAKING TERATOGENIC MEDICATIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
P56 | ARE THERE DIFFERENCES? SHBG LEVELS, FREE TESTOSTERONE AND SEXUAL PAIN IN WOMEN USING COMBINED HORMONAL CONTRACEPTION: A RETROSPECTIVE STUDY IN VULVODYNIA PATIENTS |
P57 | PARTNERSHIP CHARACTERISTICS AS PREDICTORS FOR CHOOSING A VERY EFFECTIVE CONTRACEPTIVE METHOD |
P58 | UNMET DEMAND FOR STERILIZATION AMONG LATINAS |
P59 | EXAMINING THE INFLUENCE OF MATERNAL CHARACTERISTICS ON THE USE OF CONTRACEPTION AFTER ABORTION IN THE UNITED STATES USING THE 2002 NATIONAL SURVEY OF FAMILY GROWTH |
P60 | MEDICAL VERSUS SURGICAL ABORTION: THE IMPORTANCE OF WOMEN’S CHOICE |
P61 | WOMEN’S ATTITUDES AND BEHAVIORS TOWARD UNPLANNED PREGNANCY: A PROSPECTIVE STUDY |
P62 | CHANGES IN SERVICE DELIVERY PATTERNS AFTER LAUNCHING TELEMEDICINE PROVISION OF MEDICATION ABORTION IN IOWA |
P63 | HAS MIFEPRISTONE MEDICAL ABORTION EXPANDED ABORTION ACCESS IN NEW MEXICO? A SURVEY OF OB/GYN AND FAMILY MEDICINE PHYSICIANS |
P64 | REPRODUCTIVE HEALTH PROGRAM: OUTCOMES OF A UNIQUE ABORTION TRAINING PROGRAM |
P65 | “ARE WE EVEN SPEAKING THE SAME LANGUAGE?”: CONTESTED DEFINITIONS OF RAPE, INCEST, AND LIFE ENDANGERMENT UNDER THE HYDE AMENDMENT |
P66 | STANDARDIZING EARLY ABORTION COMPLICATION DEFINITIONS AND TRACKING: TESTING AN EVIDENCE-BASED FRAMEWORK |
P67 | OVULATION RESUMPTION AFTER MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL |
P68 | PRELIMINARY RESULTS OF THE ROLE OF SEMIQUANTITATIVE PREGNANCY TESTS IN MEDICAL ABORTION PROVISION |
P69 | PREVENTING REPEAT ABORTION: IS THE IMMEDIATE INSERTION OF INTRAUTERINE DEVICES POST-ABORTION ASSOCIATED WITH FEWER REPEAT ABORTIONS IN A CANADIAN POPULATION? |
P70 | DILATION AND EVACUATION VS. LABOR INDUCTION FOR FETAL INDICATIONS: A RETROSPECTIVE COHORT STUDY |
P71 | ABORTION PRACTICE AND NEED FOR TRAINING IN MEXICO: RESULTS FROM A SURVEY OF MEXICAN PROVIDERS AT THE 2009 ANNUAL OBSTETRICS AND GYNECOLOGY SPECIALTY CONFERENCE |
P72 | CONTRACEPTIVE CHOICES OF OVERWEIGHT AND OBESE WOMEN IN A PUBLICALLY FUNDED HOSPITAL: CLINICAL IMPLICATIONS |
P73 | IMPACT OF GESTATIONAL AGE ON PAIN PERCEPTION DURING FIRST TRIMESTER SURGICAL ABORTION |
P74 | IMPACT OF A SPECIALTY ROTATION IN FAMILY PLANNING ON OBSETRICS AND GYNEOCLOGY RESIDENTS’ SELF-ASSESSMENT OF COMPETENCY AND INTENTIONS TO PROVIDE ABORTION SERVICES AFTER GRADUATION |
P75 | THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL AT 57-63 DAYS VERSUS 64-70 DAYS GESTATION |
P76 | MUSIC IN SURGICAL ABORTION CARE: A RANDOMIZED CONTROLLED PILOT STUDY |
P77 | CAN THE PROSPECT OF INFERTILITY MOTIVATE YOUNG WOMEN’S INTENTIONS TO SEEK PREVENTIVE HEALTHCARE? FINDINGS FROM CDC CONCEPT TESTING FOCUS GROUPS |
P78 | HIGH-RISK SEXUAL BEHAVIOUR IN A RANDOM SAMPLE OF >22,000 MEN FROM THE GENERAL POPULATION IN DENMARK |
P79 | EXPERIENCES OF DISCRIMINATION AND STI TESTING IN WHITE AND BLACK WOMEN |
P80 | MISSED OPPORTUNITIES FOR CHLAMYDIA RETESTING AT LIMITED SERVICE VISITS IN CALIFORNIA FAMILY PLANNING CLINICS |
P81 | THE BABOON (PAPIO ANUBIS) AS A NOVEL MODEL OF CHLAMYDIA TRACHOMATIS PELVIC INFLAMMATORY DISEASE FOR TESTING INTRAUTERINE CONTRACEPTION |
P82 | IMIQUIMOD 2.5% AND 3.75% APPLIED DAILY FOR UP TO 8 WEEKS TO TREAT EXTERNAL GENITAL WARTS |
P83 | ELDERLY PERSON’S REPRODUCTIVE HEALTH CHALLENGES AND INVOLVEMENT IN RISKY SEXUAL ACTIVITIES IN IKORODU, NIGERIA |
P84 | PREDICTORS OF SEXUAL SATISFACTION AMONG YOUNG ADULTS IN THE UNITED STATES |
P85 | REPRODUCTIVE AND SEXUAL HEALTH IN MENTALLY ILL |
P86 | SEXUAL INTIMATE PARTNER VIOLENCE, SEXUAL RISK BEHAVIORS, AND CONTRACEPTIVE PRACTICES AMONG WOMEN OF AFRICAN DESCENT |
P87 | REPRODUCTIVE HEALTHCARE NEEDS OF HIV-POSITIVE WOMEN |
P88 | CONTRACEPTIVE KNOWLEDGE, ATTITUDES, AND PRACTICES AMONG HIV-INFECTED WOMEN AND MEN RECEIVING HIV CARE AND TREATMENT IN NYANZA PROVINCE, KENYA |
P89 | HIGH CONTRACEPTION USE AND LOW PREGNANCY RATE AMONG HIV POSITIVE WOMEN ATTENDING A POSTNATAL PROGRAM IN LILONGWE, MALAWI |
P90 | INTRAUTERINE LIDOCAINE INFUSION FOR PAIN MANAGEMENT DURING OUTPATIENT TRANSCERVICAL TUBAL STERILIZATION |
P91 | RISK FACTORS FOR AND CONSEQUENCES OF UNINTENDED PREGNANCY AMONG LATINA AND WHITE POPULATIONS IN UTAH, 2004-2007 |
P92 | COMPARISON OF LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA FOR TREATMENT FOR MENORRHAGIA |
P93 | PRESUMPTIVE TREATMENT OF ABNORMAL EARLY PREGNANCY OF UNKNOWN LOCATION |
P94 | VAGINAL AND RECTAL CLOSTRIDIAL COLONIZATION AMONG WOMEN OF REPRODUCTIVE AGE IN THE UNITED STATES |
P95 | TWO-STAGE CLUSTER SAMPLING WITH REFERRAL: IMPROVING THE EFFICIENCY OF ESTIMATING UNMET NEEDS AMONG PREGNANT AND POSTPARTUM WOMEN AFTER FLOODING IN NORTHWEST GEORGIA, SEPTEMBER 2009 |
P96 | RURAL REPRODUCTIVE HEALTH: BARRIERS AND FACILITATORS EXPERIENCED BY LOW-INCOME RURAL WOMEN IN OBTAINING REPRODUCTIVE HEALTH CARE SERVICES |
P97 | EFFECT OF A “CONTRACEPTIVE VITAL SIGN” IN PRIMARY CARE: A RANDOMIZED CONTROLLED TRIAL |
P98 | ASSOCIATION BETWEEN ECONOMIC VULNERABILITY AND WOMEN’S PREGNANCY INTENTIONS |
P99 | IMPACT OF LENGTH OF FORMAL FAMILY PLANNING TRAINING ON SELF-ASSESSED COMPETENCE AND PROCEDURE VOLUME OF ABORTION PROCEDURES |
P100 | IMPACT OF FORMAL FAMILY PLANNING TRAINING ON OB-GYN RESIDENTS SKILLS AND EXPOSURE IN CONTRACEPTION PROVISION |
P101 | INNOVATION IN EMERGENCY OBSTETRIC TRAINING, PRONTO2: AN IN SITU MULTI-DISCIPLINARY, LOW-TECH, HIGH-FIDELITY SIMULATION-BASED CURRICULUM FOR MEXICO, RESULTS OF A PILOT IMPLEMENTATION STUDY |
P102 | CONTRACEPTION USE AFTER AN UNPLANNED PREGNANCY |
About Dr. Kate Gundy MD